Trial Outcomes & Findings for Investigations of Ear Tip Performance, Perceptions, and Experiences (NCT NCT05725824)
NCT ID: NCT05725824
Last Updated: 2024-07-29
Results Overview
Evaluation of ear canal acoustics with participant wearing a hearing aid and earmold type (3d party control, in-house\_Resin, in-house\_PLA). Then, a thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples. Results are recorded in gain (dB SPL) across frequencies. Once complete, the earmold type is changed and recording is repeated until all ear mold material types have been tested for each individual. Arms/Groups were collapsed for RM-ANOVA to compare between various earmold types. A post-hoc paired t-test w/ Bonferroni correction was utilized to compare ear mold material types.
COMPLETED
NA
30 participants
15 minutes
2024-07-29
Participant Flow
Participant milestones
| Measure |
3rd Party Control, Then In-house PLA, Then In-house_RES
In this arm, participants were first fit and tested with a 3rd party control, then in-house PLA, then in-house\_RES earmold
|
In-house_RES, Then 3rd Party Control, Then In-house PLA
In this arm, participants were first fit and tested with a in-house\_RES, then 3rd party control, then a in-house\_PLA earmold
|
In-house PLA, Then In-house_RES, Then 3rd Party Control
In this arm, participants were fit with a in-house PLA, then in-house\_RES, then 3rd party control earmold.
|
|---|---|---|---|
|
Overall Study
STARTED
|
10
|
10
|
10
|
|
Overall Study
COMPLETED
|
10
|
10
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Investigations of Ear Tip Performance, Perceptions, and Experiences
Baseline characteristics by cohort
| Measure |
Overall Group
n=30 Participants
Crossover trial of 30 individuals with normal hearing
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
30 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
24 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic/Latino
|
7 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White/Non-hispanic
|
14 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
More than one race
|
4 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 15 minutesEvaluation of ear canal acoustics with participant wearing a hearing aid and earmold type (3d party control, in-house\_Resin, in-house\_PLA). Then, a thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples. Results are recorded in gain (dB SPL) across frequencies. Once complete, the earmold type is changed and recording is repeated until all ear mold material types have been tested for each individual. Arms/Groups were collapsed for RM-ANOVA to compare between various earmold types. A post-hoc paired t-test w/ Bonferroni correction was utilized to compare ear mold material types.
Outcome measures
| Measure |
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
|
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
|
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
|
|---|---|---|---|
|
Real Ear Measures
REAG_2000s
|
61.23 dB SPL
Standard Deviation 2.49
|
60.23 dB SPL
Standard Deviation 2.01
|
60.5 dB SPL
Standard Deviation 2.27
|
|
Real Ear Measures
REAG_1000m
|
64.53 dB SPL
Standard Deviation 2.61
|
66.5 dB SPL
Standard Deviation 2.73
|
66.23 dB SPL
Standard Deviation 2.65
|
|
Real Ear Measures
REAG_500l
|
74.43 dB SPL
Standard Deviation 2.01
|
75.4 dB SPL
Standard Deviation 2.11
|
74.5 dB SPL
Standard Deviation 2.00
|
|
Real Ear Measures
REAG_1000l
|
70.83 dB SPL
Standard Deviation 2.57
|
72.23 dB SPL
Standard Deviation 3.17
|
71.8 dB SPL
Standard Deviation 3.40
|
PRIMARY outcome
Timeframe: 2nd listening session appointment (15 minutes)A questionnaire eliciting patient perception of physical comfort, quality of voice, and overall self-perceived satisfaction. Includes 12 items (5 point) that are scored on a 0 to 100, with 100 representing best possible function/rating
Outcome measures
| Measure |
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
|
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
|
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
|
|---|---|---|---|
|
Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
PerceptVoice
|
3.6 score on a scale
Standard Deviation 0.97
|
3.77 score on a scale
Standard Deviation 1.22
|
3.6 score on a scale
Standard Deviation 1.22
|
|
Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
NaturalSound
|
3.17 score on a scale
Standard Deviation 1.02
|
3.43 score on a scale
Standard Deviation 1.25
|
3.3 score on a scale
Standard Deviation 1.12
|
|
Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
PhysComfort
|
3.9 score on a scale
Standard Deviation 0.97
|
4 score on a scale
Standard Deviation 1.11
|
3.73 score on a scale
Standard Deviation 1.05
|
PRIMARY outcome
Timeframe: Prior to 2nd listening session appointment (15 minutes)Physical dimensions of each ear mold type (3rd party Control, in-house\_Resin, in-house\_PLA) were taken using digital calipers in millimeters prior to being worn by participants.
Outcome measures
| Measure |
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
|
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
|
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
|
|---|---|---|---|
|
Physical Dimensions
HeightTotal
|
27.19 millimeters
Standard Deviation 2.01
|
27.73 millimeters
Standard Deviation 1.92
|
27.39 millimeters
Standard Deviation 1.85
|
|
Physical Dimensions
WidthTotal
|
21.42 millimeters
Standard Deviation 3.76
|
22.50 millimeters
Standard Deviation 3.55
|
22.23 millimeters
Standard Deviation 3.49
|
|
Physical Dimensions
VentDiam
|
2.56 millimeters
Standard Deviation 0.41
|
2.51 millimeters
Standard Deviation 0.37
|
2.23 millimeters
Standard Deviation 0.36
|
|
Physical Dimensions
DepthTotal
|
15.25 millimeters
Standard Deviation 1.66
|
13.88 millimeters
Standard Deviation 2.26
|
13.65 millimeters
Standard Deviation 1.86
|
|
Physical Dimensions
Height_mEC
|
7.72 millimeters
Standard Deviation 1.13
|
8.21 millimeters
Standard Deviation 0.91
|
8.38 millimeters
Standard Deviation 0.99
|
PRIMARY outcome
Timeframe: Prior to 2nd listening session appointment (15 minutes)The total raw cost ($) for each ear mold type (3rd party\_control, in-house\_RES, and in-house\_PLA).
Outcome measures
| Measure |
3rd Party Control
n=30 Participants
Participants each wore and were tested with 3rd party control ear mold for 15 minutes.
|
In-house_RES
n=30 Participants
Participants each wore and were tested with study in-house\_RES ear mold for 15 minutes.
|
In-house_PLA
n=30 Participants
Participants each wore and were tested with study in-house\_PLA ear mold for 15 minutes.
|
|---|---|---|---|
|
Production Variable
|
59.95 dollars ($)
Standard Deviation 0.00
|
1.29 dollars ($)
Standard Deviation 0.20
|
0.04 dollars ($)
Standard Deviation 0.00
|
Adverse Events
3rd Party Control, Then In-house_PLA, Then In-house_Resin
In-house_Resin, Then 3rd Party Control, Then In-house_PLA
In-house_PLA, Then In-house_Resin, Then 3rd Party Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place